Lot certificates published
Plain, secure packaging

fragment of

Oxyntomodulin vs Glucagon

The complete glucagon residue sequence forms the N-terminal portion of oxyntomodulin. Oxyntomodulin has an additional eight-residue C-terminal extension.

Published: 2026-10-03Library record comparison: 2026-10-03

01

Identity side by side

Recorded molecular identities of Oxyntomodulin and Glucagon
Recorded fieldOxyntomodulinGlucagon
Canonical nameOxyntomodulinGlucagon
AliasesOXM; Glucagon-37Glucagon(1-29)
Development codesnot recordednot recorded
CASnot recorded16941-32-5
UNIILV7ELH7V1676LA80IG2G
PubChem CID12149408816132283
Molecular formulaC192H295N61O60SC153H225N43O49S
Molecular weight (Da)4449.93482.8
Sequence length (residues)3729
Terminal modificationsFree N-terminus; Free C-terminal carboxylFree N-terminus; Free C-terminal carboxyl
Structural modificationsnot recordednot recorded

Oxyntomodulin: nomenclature notes

Oxyntomodulin is ONE peptide, not a mixture of GLP-1 and glucagon. It is also not glicentin, which is a larger processing product that contains the oxyntomodulin region — and both carry the same KRNRNNIA C-terminus, so recognising that region does not distinguish them. Separately, 'oxyntomodulin-like' is a description of GLP-1R/GCGR pharmacology and does not establish oxyntomodulin-derived chemistry; a compound can have that pharmacology from a different scaffold entirely. PubChem CID 121494088 encodes the human 37-residue free peptide ending KRNRNNIA, whereas CID 16144019 ends KRNKNNIA and contains Lys33 in place of Arg33. Arginine carries two more nitrogens than lysine, which is why that record shows N59 against this entry's N61. Its formula and mass describe a variant and must not be applied to the human sequence.

Glucagon: nomenclature notes

Mature glucagon, not proglucagon and not a generic glucagon-family peptide. PubChem CID 16132283 encodes the free 29-residue peptide, whereas CAS-associated CIDs 91820614 and 16186213 include acetate and hydrochloride components, respectively. Glucagon, GLP-1 and oxyntomodulin are related through processing of a shared precursor but are not aliases. Note particularly that this entire 29-residue sequence is contained within oxyntomodulin, which extends it by eight residues — that containment is exactly why the two are analytically difficult to separate.

02

Residue sequence comparison

Positions are numbered from each stored sequence’s first residue. Highlighted cells differ or extend beyond the other chain; a dash indicates no aligned residue. One-letter notation does not encode terminal groups or stereochemistry. Read the recorded notes below.

Aligned one-letter residue sequences
Oxyntomodulin1H2S3Q4G5T6F7T8S9D10Y11S12K13Y14L15D16S17R18R19A20Q21D22F23V24Q25W26L27M28N29T30K31R32N33R34N35N36I37A
Glucagon1H2S3Q4G5T6F7T8S9D10Y11S12K13Y14L15D16S17R18R19A20Q21D22F23V24Q25W26L27M28N29T·—·—·—·—·—·—·—·—

Differences in the one-letter sequence

  • Oxyntomodulin: residue 30 = K; Glucagon: no aligned residue.
  • Oxyntomodulin: residue 31 = R; Glucagon: no aligned residue.
  • Oxyntomodulin: residue 32 = N; Glucagon: no aligned residue.
  • Oxyntomodulin: residue 33 = R; Glucagon: no aligned residue.
  • Oxyntomodulin: residue 34 = N; Glucagon: no aligned residue.
  • Oxyntomodulin: residue 35 = N; Glucagon: no aligned residue.
  • Oxyntomodulin: residue 36 = I; Glucagon: no aligned residue.
  • Oxyntomodulin: residue 37 = A; Glucagon: no aligned residue.

Further differences are recorded in the sequence notes.

Oxyntomodulin

Terminal modifications
Free N-terminus; Free C-terminal carboxyl
Structural modifications
not recorded
Sequence notes
Thirty-seven residues, free at both termini. The first twenty-nine are the complete glucagon sequence; the C-terminal extension is KRNRNNIA. Species and the extension must both be explicit.

Glucagon

Terminal modifications
Free N-terminus; Free C-terminal carboxyl
Structural modifications
not recorded
Sequence notes
Twenty-nine residues, free at both termini, no modifications.

03

Recorded mechanisms

These lists show the links recorded in each monograph. An unlisted link does not establish its absence from the molecule’s biology.

Shared recorded links

Recorded only for Oxyntomodulin

Recorded only for Glucagon

not recorded

04

Recorded compound classes

Recorded only for Oxyntomodulin

not recorded

Recorded only for Glucagon

not recorded

05

References for the relationship

  1. Reference 1

    Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.

    Blache P, Kervran A, Martinez J, Bataille D

    Analytical biochemistry · 1988-08-15 · Journal Article

    current
  2. Reference 2

    Quantification of glucagon and oxyntomodulin by protein precipitation-immunoaffinity enrichment-LC-MS/MS.

    Becker JO, Shijo SK, Huynh HH, Forrest KL, MacCoss MJ, Emrick MA, Goonatilleke E, Hoofnagle AN

    Journal of mass spectrometry and advances in the clinical lab · 2025-04-11 · Journal Article

    current

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Blache P et al. 1988Study models reported: in vitro · from the abstract
Becker JO et al. 2025Study models reported: in vitro · from the abstract

06

Read the full monographs